Backlash Against Drug Prices Hits Manufacturers and Middlemen

Backlash Against Drug Prices Hits Manufacturers and Middlemen

The drug industry is showing signs it is slowing the pace of price increases after years of hefty hikes, alarming shareholders worried that pressure from politicians, consumers and employers will continue to stifle pricing power.

Shares of many drugmakers, wholesale distributors and pharmacy-benefit managers were battered Friday on new evidence in corporate earnings reports that pharmaceutical companies are declining to ratchet up prices as sharply as in previous years.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / Backlash Against Drug Prices Hits Manufacturers and Middlemen